You can now read 10 articles a month for free. Read as much as you want anywhere and anytime for just 99¢.

BioMed Realty Trust to buy Cambridge Place for $119m

BioMed Realty Trust Inc., a San Diego-based real estate investment trust that focuses on the life sciences industry, said it has agreed to buy Cambridge Place for $119 million.

When completed, the transaction would expand BioMed’s real estate portfolio in the Greater Boston-Cambridge market to about 3.2 million square feet of space, the company said in a press release.

Continue reading below

Cambridge Place is made up of three buildings that collectively have about 287,000 square feet of space. The property is 80-percent leased, and tenants include CDM Smith Inc., an engineering and construction firm, and Idenix Pharmaceuticals Inc., a biopharmaceutical company.

In a statement, BioMed Realty chairman and chief executive Alan D. Gold said: “We are very excited about the acquisition of Cambridge Place, which expands our portfolio and our ability to meet the need for life science space in Cambridge, the preeminent life science market in the world. Similar to our recent investments in Ardsley Park in New York and Research Boulevard in Maryland, the addition of Cambridge Place to our portfolio provides a compelling value creation opportunity through our superior lease execution and property operating expertise.”

Chris Reidy can be reached at reidy@globe.com.
Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week